Clinical Trials Logo
  1. Home
  2. Obesity
  3. NCT02404090
  4. Details
NCT02404090 Clinical Trial

Impact of the Excess Weight Loss on Mineralization Patterns of the Knee After Bariatric Operations

Obesity Clinical Trial

— CT-OAM  

Official title:
Impact of the Excess Weight Loss on Mineralization Patterns of the Knee After Bariatric Operations - a Prospective CT-osteoabsorptiometry-based Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT02404090
Other study ID # SLS-001
Secondary ID
Status Not yet recruiting
Phase N/A
First received March 26, 2015
Last updated March 26, 2015
Start date August 2015
Est. completion date August 2021

Study information
Verified date March 2015
Source Spital Limmattal Schlieren
Contact Marko Kraljevic, MD
Email marko.kraljevic@gmail.com
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Observational

Clinical Trial Summary

Evaluation of the subchondral mineralization plate after excess weight loss in patientes undergoing bariatric operation by means of CT-osteoabsorptiometry.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 50
Est. completion date August 2021
Est. primary completion date August 2020
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- BMI > 35

- need for bariatric operation

- knee pain (VAS > 2)

Exclusion Criteria:

- malignancy

- poor compliance

- previous bariatric operation

- pregnancy

- lack of knee pain (VAC < 2)

- previous knee operation

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Radiation:
• CT-osteoarbsorptiometry
Conventional CT-scan analyzed by means of a specific tool (Analyze, Mayo Clinic).

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Marko Kraljevic

Outcome
Type Measure Description Time frame Safety issue
Primary Mineralization changes after excess weight loss? 5 years No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2